Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study.
Year: 2017
Type: article
Study design: Observational Study
Source: PubMed
Authors: Gokmen Aktas, Tulay Kus, Mehmet Emin Kalender, Selim Kervancioglu, Alper Sevinc, Seval Kul, Celaletdin Camci
Institutions: Gaziantep Onkoloji Hastanesi, Gaziantep University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2609170905
